ERBB2 and ductal breast carcinoma in situ: HER2 gene amplification and protein overexpression are detected in up to 70% of poorly differentiated DCIS cases [7], and cyclin D1 is amplified and overexpressed in DCIS [8] in approximately 20% of the cases.